GlaxoSmithKline logo

GSK - GlaxoSmithKline Share Price

1640p -22.0  -1.3%

Last Trade - 13/09/19

Large Cap
Market Cap £81.81bn
Enterprise Value £110.42bn
Revenue £31.76bn
Position in Universe 18th / 1830
Unlock GSK Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


GSK Revenue Unlock GSK Revenue

Net Income

GSK Net Income Unlock GSK Revenue

Normalised EPS

GSK Normalised EPS Unlock GSK Revenue

PE Ratio Range

GSK PE Ratio Range Unlock GSK Revenue

Dividend Yield Range

GSK Dividend Yield Range Unlock GSK Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
GSK EPS Forecasts Unlock GSK Revenue
Profile Summary

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.

Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated December 6, 1999
Public Since May 22, 1972
No. of Shareholders: 109,855
No. of Employees: 95,490
GSK Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for GSK
Upcoming Events for GSK
Thursday 26th September, 2019
GlaxoSmithKline PLC Vaccines Investor Event
Monday 30th September, 2019
GlaxoSmithKline PLC Corporate Call
Wednesday 30th October, 2019
Q3 2019 GlaxoSmithKline PLC Earnings Release
Wednesday 5th February, 2020
Q4 2019 GlaxoSmithKline PLC Earnings Release
Similar to GSK
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.